A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians)
Andrea Rabbione(ASST Fatebenefratelli Sacco), Matteo Passerini(University of Milan), Simona Landonio(ASST Fatebenefratelli Sacco), Gina A. Suh(European Society of Clinical Microbiology and Infectious Diseases), Riccardo De Giorgi(Warneford Hospital), Andrea Gori(University of Milan), Chiara Mariani, Antonella Foschi(ASST Fatebenefratelli Sacco), Maria Vittoria Cossu(Luigi Sacco Hospital), Aurora Civati(ASST Fatebenefratelli Sacco), Martina Offer(University of Milan), F Petri(ASST Fatebenefratelli Sacco), Dario Cattaneo(Humanitas University), Letizia Scandiffio(ASST Fatebenefratelli Sacco), Aaron J Tande(Mayo Clinic in Arizona), Alberto Dolci(University of Milan)
Cited by 0
Related Papers
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
|The Lancet Infectious Diseases|2023|137
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2000|115
Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2000|97